On July 8, Nasdaq-listed medical device technology company BioSig Technologies announced a merger with another Nasdaq-listed company, Streamex Exchange Corporation, and signed a financing agreement of up to $1.1 billion, aimed at advancing RWA tokenization business development and promoting the on-chain process of the $142 trillion commodity market with a focus on gold tokenization.
The company will sell $100 million in senior secured convertible bonds and a $10 billion equity credit line, with this transaction led by Cantor Fitzgerald as joint lead placement agents for Tether's asset custodian.
Streamex is a wholly-owned subsidiary of BioSig Technologies, Inc., and a company focused on real-world asset (RWA) tokenization in the commodity sector. Streamex's goal is to bring the commodity market on-chain and has developed the primary issuance and trading infrastructure that will fundamentally transform commodity finance.
